Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack F Wetzels

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Kidney International|February 21, 2025
Kidney-limited thrombotic microangiopathy and eculizumab responseJack F Wetzels
The New England Journal of Medicine|March 5, 2015
Blood pressure in early autosomal dominant polycystic kidney diseaseJack F Wetzels
Kidney International|July 20, 2025
Is the Mayo prediction tool for MGRS ready for prime time?Jack F Wetzels
Nature Reviews. Nephrology|January 20, 2017
Glomerular disease in 2016: New advances in the treatment of glomerular diseaseRutger J Maas, Jack F Wetzels
Nature Reviews. Nephrology|July 22, 2015
Therapy: Maintenance of steroid-free remission in nephrotic syndromeJeroen K Deegens, Jack F Wetzels
Nature Reviews. Nephrology|June 25, 2014
Glomerular disease: The search goes on: suPAR is not the elusive FSGS factorJeroen K Deegens, Jack F Wetzels
Kidney360|April 4, 2022
Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: CONAnne-Els van de Logt, Jack F Wetzels
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 15, 2017
Urinary Excretion of α<sub>1</sub>-Microglobulin Does Not Predict Graft Loss in Stable Kidney Transplant RecipientsAnneke P Bech, Judith M Hoogendijk, Jack F Wetzels
Kidney International|September 17, 2005
Screening for microalbuminuriaLuuk B Hilbrands, Frans T Huysmans, Jack F Wetzels
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 23, 2014
Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the futureRutger J Maas, Jeroen K Deegens, Jack F Wetzels
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Kidney International|February 21, 2025
Kidney-limited thrombotic microangiopathy and eculizumab responseJack F Wetzels
The New England Journal of Medicine|March 5, 2015
Blood pressure in early autosomal dominant polycystic kidney diseaseJack F Wetzels
Kidney International|July 20, 2025
Is the Mayo prediction tool for MGRS ready for prime time?Jack F Wetzels
Nature Reviews. Nephrology|January 20, 2017
Glomerular disease in 2016: New advances in the treatment of glomerular diseaseRutger J Maas, Jack F Wetzels
Nature Reviews. Nephrology|July 22, 2015
Therapy: Maintenance of steroid-free remission in nephrotic syndromeJeroen K Deegens, Jack F Wetzels
Nature Reviews. Nephrology|June 25, 2014
Glomerular disease: The search goes on: suPAR is not the elusive FSGS factorJeroen K Deegens, Jack F Wetzels
Kidney360|April 4, 2022
Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: CONAnne-Els van de Logt, Jack F Wetzels
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 15, 2017
Urinary Excretion of α<sub>1</sub>-Microglobulin Does Not Predict Graft Loss in Stable Kidney Transplant RecipientsAnneke P Bech, Judith M Hoogendijk, Jack F Wetzels
Kidney International|September 17, 2005
Screening for microalbuminuriaLuuk B Hilbrands, Frans T Huysmans, Jack F Wetzels
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 23, 2014
Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the futureRutger J Maas, Jeroen K Deegens, Jack F Wetzels
Pageof 6